ActBlue CEO Regina Wallace-Jones is set to appear before House lawmakers as Republicans intensify their investigation into whether the Democratic fundraising platform misled Congress about its donor fraud safeguards.
Wallace-Jones is scheduled to testify before the House Administration Committee, where lawmakers are expected to press her on ActBlue’s handling of overseas donations and its internal fraud-prevention practices. The hearing marks a significant moment in a congressional probe that has stretched on for years and has centered on whether the online payment processor did enough to prevent unlawful political donations.
Hours before the hearing was set to begin, Wallace-Jones said in a Washington Post op-ed that she planned to invoke her Fifth Amendment right against self-incrimination when questioned by lawmakers.
ActBlue has repeatedly denied that it lied to Congress. Representatives for the group have also argued that the Republican-led investigation is politically motivated.
Earlier this week, an attorney for Wallace-Jones asked House Administration Committee Chairman Bryan Steil, R-Wis., to issue a subpoena for her testimony. The request came despite Wallace-Jones having previously agreed in May to appear voluntarily before the committee on June 10.
Republicans quickly moved forward with the subpoena. A source familiar with the matter told Fox News Digital that Wallace-Jones still planned to attend the hearing.
House Judiciary Committee Chairman Jim Jordan, R-Ohio, and House Oversight Committee Chairman James Comer, R-Ky., are also expected to participate in the hearing and question Wallace-Jones. Both lawmakers have been involved in the broader ActBlue investigation.
Steil has framed the inquiry as an effort to ensure foreign money does not enter American elections through online fundraising platforms.
“The goal of this investigation remains the same: to ensure that federal law effectively stops bad actors, including foreign actors, from making political donations to American candidates and campaigns through online fundraising platforms,” Steil wrote in a Wednesday letter to Wallace-Jones that accompanied the subpoena request reviewed by Fox News Digital.
The House Administration Committee has been examining ActBlue since 2023, focusing on the platform’s fraud screening systems and its processing of donations that may have originated overseas. Under federal law, foreign nationals who are not U.S. residents are generally barred from contributing to federal and state candidates, candidate committees, and political action committees.
Republicans sharpened their scrutiny of ActBlue after The New York Times reported earlier this year that the group’s former outside counsel had warned Wallace-Jones she may have made false statements to Steil’s committee about ActBlue’s anti-fraud practices. According to the report, attorneys found that some safeguards described to congressional investigators were not always being followed in the way lawmakers had been told.
The Times also reported that ActBlue did not immediately correct the record with the committee, even though it updated donor screening practices internally. ActBlue later acknowledged in a June 2025 letter to Steil’s committee that certain fraud-prevention procedures had been strengthened.
Republicans have argued that the gap between ActBlue’s statements to Congress and its internal practices may have been “an attempt to avoid negative attention,” as Steil wrote in a Tuesday letter to Wallace-Jones.
The committee has also criticized ActBlue personnel for what Republicans describe as a lack of full cooperation. Five current and former ActBlue employees invoked their Fifth Amendment rights a combined 146 times after being subpoenaed to testify.
The investigation has expanded beyond Wallace-Jones. Earlier in June, Steil requested transcribed interviews with five members of ActBlue’s board of directors. Lawmakers want to ask them about the group’s response to congressional scrutiny and about internal turmoil that followed concerns over whether Wallace-Jones misled Congress.
The New York Times also reported that two unions affiliated with ActBlue warned the board about a “growing pattern of volatility and toxicity” among leadership, including alleged retaliation against a whistleblower.
Steil’s panel has requested documents from ActBlue board members as well. Those individuals have until June 16 to comply, according to a letter previously obtained by Fox News Digital.
